Series A Biopharma Companies

Solstice Oncology develops immuno-oncology therapies focused on treating and preventing cancer through targeted approaches.

Altos Labs focuses on cellular rejuvenation programming to restore cell health and resilience, to reverse disease to transform medicine.

SiccaNova Therapeuticsis a startup developing novel low-molecular therapeutics targeting dry mouth (xerostomia) and dry eye conditions.

ClostraBio is a biopharma company developing therapeutics for food allergies.

Seeker Biologics aims to make new medicines for allergic, autoimmune and inflammatory diseases.

Breye Therapeutics, a biopharmaceutical firm that provide cutting-edge oral treatments for the management of retinal vascular diseases.

Mirai Bio provides access to end-to-end development capabilities with innovation at every step.

Typewriter Therapeutics develops mRNA-based gene therapies using a gene writing platform for site-specific insertion of therapeutic genes.

Boost Biomes develops microbial products to sustainably improve food production and shelf-life.

Matisse Pharmaceuticals is a biopharmaceutical company developing therapies for sepsis and septic shock by targeting cytotoxic histones.

Elevian develops medicines that restore youthful regenerative capacity with the potential to treat and prevent many age-related diseases.

RegCell develops cell therapies designed to restore immune tolerance in autoimmune diseases.

Tafalgie Therapeutics is a CNRS and AMU spin-off company engaged in biopharmaceutical research.

3T Biosciences is an immunotherapy company that develops next-generation therapies for cancer and immune-mediated diseases.

Oisin Biotechnologies is a drug development company focused on mitigating the senolytic technology to combat age-related diseases.

Jocasta Neuroscience is a biotech company that offers healthcare services.

Tikva Allocell is a biotechnology company that specializes in next-gen cell therapies.

Renalys Pharma is a clinical-stage biopharmaceutical company developing therapeutics for renal disease in Asian patients.

Enabling immune infiltration of the tumor microenvironment

Algae-C is a biotechnology company.

Kantum Pharma is developing a specific AKI therapy to help critical care clinicians prevent hundreds of thousands of deaths from AKI.

Mammogen specializes in improving the detection, diagnosis, and treatment of breast cancer, from end-to-never-end.

Anodyne Nanotech is a preclinical-stage biotech company that develops differentiated, transdermal forms of high-value drugs.

Rapalogix Health is a biotechnology company focused on developing longevity-based solutions for skin health and dermatological conditions.

LatchBio is a biotech research company that provides code-free platform for the biocomputing revolution.